ROPIVACAINE KABI ropivacaine hydrochloride 40 mg/20 mL solution for injection ampoule Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

ropivacaine kabi ropivacaine hydrochloride 40 mg/20 ml solution for injection ampoule

fresenius kabi australia pty ltd - ropivacaine hydrochloride, quantity: 40 mg - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; sodium hydroxide; water for injections - surgical anaesthesia (adults and children over 12 years of age); epidural block for surgery including caesarean section; intrathecal anaesthesia; field block (minor nerve block and infiltration); major nerve block. analgesia (adults and children over 12 years of age); continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain; field block (minor nerve block and infiltration); continuous peripheral nerve block infusion or intermittent injections for post operative pain management; continuous wound infusion for postoperative pain management (adults only). analgesia (children aged 0 - 12 years); caudal epidural block in neonates (> 37 weeks gestation and over 2500 g weight), infants and children up to and including 12 years. continous epidural infusion in infants (> 30 days and over 2500 g weight) and children up to and including 12 years; peripheral nerve block in children aged 1 up to and including 12 years. for peri- and postoperative pain management. there are no safety or efficacy data to support the use of ropivacaine hydrochloride for analgesia for longer than 72 hours. (data for peripheral nerve block administered as a continuous peripheral infusion or intermittent injections and for continuous wound infusion support the use for up to 48 hours only).

ROPIVACAINE KABI ropivacaine hydrochloride 20 mg/10 mL solution for injection ampoule Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

ropivacaine kabi ropivacaine hydrochloride 20 mg/10 ml solution for injection ampoule

fresenius kabi australia pty ltd - ropivacaine hydrochloride, quantity: 20 mg - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; sodium hydroxide; water for injections - surgical anaesthesia (adults and children over 12 years of age); epidural block for surgery including caesarean section; intrathecal anaesthesia; field block (minor nerve block and infiltration); major nerve block. analgesia (adults and children over 12 years of age); continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain; field block (minor nerve block and infiltration); continuous peripheral nerve block infusion or intermittent injections for post operative pain management; continuous wound infusion for postoperative pain management (adults only). analgesia (children aged 0 - 12 years); caudal epidural block in neonates (> 37 weeks gestation and over 2500 g weight), infants and children up to and including 12 years. continous epidural infusion in infants (> 30 days and over 2500 g weight) and children up to and including 12 years; peripheral nerve block in children aged 1 up to and including 12 years. for peri- and postoperative pain management. there are no safety or efficacy data to support the use of ropivacaine hydrochloride for analgesia for longer than 72 hours. (data for peripheral nerve block administered as a continuous peripheral infusion or intermittent injections and for continuous wound infusion support the use for up to 48 hours only).

Paedisol Solution for Infusion Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

paedisol solution for infusion

fresenius kabi deutschland gmbh - sodium chloride; potassium chloride; calcium chloride dihydrate; magnesium chloride hexahydrate; sodium acetate trihydrate ; glucose monohydrate - solution for infusion - solutions affecting the electrolyte balance; electrolytes with carbohydrates

Hartmann’s Solution for Infusion, glass bottle Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

hartmann’s solution for infusion, glass bottle

fresenius kabi deutschland gmbh - sodium chloride; potassium chloride; calciumchloride dihydrate; sodium lactate (as 50% solution) - solution for infusion - solutions affecting the electrolyte balance; electrolytes

Hartmann’s Solution for Infusion, PPC PSEB bag Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

hartmann’s solution for infusion, ppc pseb bag

fresenius kabi deutschland gmbh - sodium chloride; potassium chloride; calcium chloride dihydrate; sodium lactate (as 50% solution) - solution for infusion - solutions affecting the electrolyte balance; electrolytes

Hartmann’s Solution for Infusion, PSEB bag Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

hartmann’s solution for infusion, pseb bag

fresenius kabi deutschland gmbh - sodium chloride; potassium chloride; calcium chloride dihydrate; sodium lactate (as 50% solution) - solution for infusion - solutions affecting the electrolyte balance; electrolytes

Hartmann’s Solution for Infusion, PVC bag Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

hartmann’s solution for infusion, pvc bag

fresenius kabi deutschland gmbh - sodium chloride; potassium chloride; calcium chloride dihydrate; sodium lactate (as 50% solution) - solution for infusion - solutions affecting the electrolyte balance; electrolytes

Hartmann's Solution for Infusion, PE bottle Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

hartmann's solution for infusion, pe bottle

fresenius kabi deutschland gmbh - sodium chloride; potassium chloride; calcium chloride dihydrate; sodium lactate (as 50% solution) - solution for infusion - solutions affecting the electrolyte balance; electrolytes

MULTIBIC potassium-free, Solution for Haemofiltration Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

multibic potassium-free, solution for haemofiltration

fresenius medical care australia pty ltd - magnesium chloride hexahydrate, quantity: 0.1017 g/l; sodium bicarbonate, quantity: 2.94 g/l; sodium chloride, quantity: 6.136 g/l; glucose monohydrate, quantity: 1.1 g/l (equivalent: glucose, qty 1 g/l); calcium chloride dihydrate, quantity: 0.2205 g/l - solution, dialysis - excipient ingredients: carbon dioxide; water for injections; hydrochloric acid; monobasic sodium phosphate dihydrate - replacement fluid, which is administered intravenously in patients with acute renal failure in intensive care units.

MULTIBIC 4 mmol/L potassium, Solution for Haemofiltration Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

multibic 4 mmol/l potassium, solution for haemofiltration

fresenius medical care australia pty ltd - glucose monohydrate, quantity: 1.1 g/l (equivalent: glucose, qty 1 g/l); sodium bicarbonate, quantity: 2.94 g/l; magnesium chloride hexahydrate, quantity: 0.1017 g/l; calcium chloride dihydrate, quantity: 0.2205 g/l; sodium chloride, quantity: 6.136 g/l; potassium chloride, quantity: 0.2982 g/l - solution, dialysis - excipient ingredients: water for injections; hydrochloric acid; carbon dioxide; monobasic sodium phosphate dihydrate - replacement fluid, which is administered intravenously in patients with acute renal failure in intensive care units.